One Stop Shop for All Your Market Research Reports

Global Transcatheter Aortic Valve Replacement (TAVR) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place. According to our (Global Info Research) latest study, the global Transcatheter Aortic Valve Replacement (TAVR) market size was valued at USD 4124.7 million in 2022 and is forecast to a readjusted size of USD 11700 million by 2029 with a CAGR of 16.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc. East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China. In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation. This report is a detailed and comprehensive analysis for global Transcatheter Aortic Valve Replacement (TAVR) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts, in consumption value ($ Million), 2018-2029 Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global Transcatheter Aortic Valve Replacement (TAVR) market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Transcatheter Aortic Valve Replacement (TAVR) To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Transcatheter Aortic Valve Replacement (TAVR) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific and Meril Life Sciences, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Transcatheter Aortic Valve Replacement (TAVR) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Transfemoral Approach Transapical Approach Others Market segment by Application Aortic Stenosis Aortic Regurgitation Others Market segment by players, this report covers Edwards Lifesciences Medtronic Abbott Boston Scientific Meril Life Sciences Venus Medtech Bracco (HLT) JenaValve Technology Suzhou Jiecheng Medical Technology Co. Peijia Medical Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Transcatheter Aortic Valve Replacement (TAVR) product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Transcatheter Aortic Valve Replacement (TAVR), with revenue, gross margin and global market share of Transcatheter Aortic Valve Replacement (TAVR) from 2018 to 2023. Chapter 3, the Transcatheter Aortic Valve Replacement (TAVR) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Transcatheter Aortic Valve Replacement (TAVR) market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Transcatheter Aortic Valve Replacement (TAVR). Chapter 13, to describe Transcatheter Aortic Valve Replacement (TAVR) research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Transcatheter Aortic Valve Replacement (TAVR) 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Transcatheter Aortic Valve Replacement (TAVR) by Type 1.3.1 Overview: Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global Transcatheter Aortic V
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 368636
Category
  • Healthcare
Published on 02-Jan
Number of Pages 102
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(30)